<?xml version="1.0" encoding="UTF-8"?>
<p>Until effective treatment options are available, the COVID-19 pandemic will continue to have a detrimental impact on healthcare and daily life. To expedite the availability of agents to treat COVID-19, repurposed medications are being clinically evaluated. Hydroxychloroquine has gained popularity as a potential treatment for COVID-19 because of its in vitro antiviral and immunomodulatory properties [
 <xref rid="B6" ref-type="bibr">6</xref>, 
 <xref rid="B7" ref-type="bibr">7</xref>, 
 <xref rid="B12" ref-type="bibr">12</xref>].
</p>
